How has Krystal Biotech, Inc.'s unrealized gains on investments changed year-over-year?

Krystal Biotech, Inc.'s unrealized gains on investments decreased by 66.5% year-over-year, from $866K to $290K.

What is the long-term trend for Krystal Biotech, Inc.'s unrealized gains on investments?

Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s unrealized gains on investments has grown at a 179.3% compound annual growth rate (CAGR), from $7K to $1.19M.

Krystal Biotech, Inc. KRYS Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

BridgeBio PharmaBBIO

——

BiogenBIIB

——

BioMarin PharmaceuticalsBMRN

——

Other financials

Income statement

See full

Revenue$116.4M+31.9%

Operating income$53.7M+48.1%

Net income$55.9M+56.5%

EPS (diluted)$1.83+52.5%

Balance sheet

See full

Cash & equivalents$501.3M+62.4%

Total debt$9.1M-5.7%

Total equity$1.3B+29.7%

Total assets$1.4B+30.0%

Cash flow

See full

Operating cash flow$80.4M+160%

CapEx$7.1M+15.2%

Free cash flow$73.2M+196%

Valuation

See full

Market cap$10.26B+45.4%

Enterprise value$9.77B+44.2%

P/E45.6×-11.3×

P/S24.6×+3.4×

Profitability

See full

Operating margin42.8%+10.2pp

Net margin53.9%+16.7pp

FCF margin56.9%+16.5pp

Returns & leverage

See full

Return on equity19.9%+6.0pp

Debt / equity0×0.0×

Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Krystal Biotech, Inc.'s unrealized gains on investments?: Krystal Biotech, Inc. (KRYS) reported unrealized gains on investments of $290K in Q1 2026.
How has Krystal Biotech, Inc.'s unrealized gains on investments changed year-over-year?: Krystal Biotech, Inc.'s unrealized gains on investments decreased by 66.5% year-over-year, from $866K to $290K.
What is the long-term trend for Krystal Biotech, Inc.'s unrealized gains on investments?: Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s unrealized gains on investments has grown at a 179.3% compound annual growth rate (CAGR), from $7K to $1.19M.